GANX insider filings

Gain Therapeutics, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-10-30. Screen GANX transaction legs live →

Insider transaction summary — last 90 days

2026-08-23 to 2026-11-21, from the filings listed below: 2 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
Weidner Jeanette — See Remarks2——1

Recent insider filings — Gain Therapeutics, Inc.

FiledFormInsiderReported transactionsSource
2026-10-303Weidner Jeanette — See RemarksHoldings only — no transactions reportedEDGAR
2026-10-304Weidner Jeanette — See RemarksGrant/award (A): 130,000 (derivative) @ $0EDGAR
2026-07-174Islam Khalid — DirectorGrant/award (A): 25,000 (derivative) @ $0EDGAR
2026-07-174Nicaise Claude — DirectorGrant/award (A): 25,000 (derivative) @ $0EDGAR
2026-07-174Melincoff Gwen A — DirectorGrant/award (A): 25,000 (derivative) @ $0EDGAR
2026-07-174Riley Jeffrey Scott — DirectorGrant/award (A): 25,000 (derivative) @ $0EDGAR
2026-07-174HASLER HANS PETER — DirectorGrant/award (A): 25,000 (derivative) @ $0EDGAR
2026-07-174GOLDSTEIN DOV A MD — DirectorGrant/award (A): 25,000 (derivative) @ $0EDGAR
2026-03-264Fuggetta Gianluca — See RemarkGrant/award (A): 50,000 (derivative) @ $0EDGAR
2026-03-264Mack Gene — CEO, President, DirectorGrant/award (A): 200,000 (derivative) @ $0EDGAR
2025-06-254Islam Khalid — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR
2025-06-254Nicaise Claude — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR
2025-06-254Melincoff Gwen A — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR
2025-06-254Riley Jeffrey Scott — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR
2025-06-254RICHMAN ERIC I — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR
2025-06-254HASLER HANS PETER — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR
2025-06-254GOLDSTEIN DOV A MD — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR
2025-03-214Fuggetta Gianluca — See RemarkGrant/award (A): 50,000 (derivative) @ $0EDGAR
2025-03-214Mack Gene — CEO, President, DirectorGrant/award (A): 200,000 (derivative) @ $0EDGAR
2025-01-074Mack Gene — CEO, President, DirectorGrant/award (A): 271,325 (derivative) @ $0EDGAR
2024-08-124Mack Gene — CFO and Interim CEOPurchase (P): 14,400 @ $1.01EDGAR
2024-08-124Islam Khalid — Executive Chairman, DirectorPurchase (P): 50,000 @ $1.00EDGAR
2024-07-014RICHMAN ERIC I — DirectorPurchase (P): 5,000 @ $1.23 · Purchase (P): 12,000 @ $1.21EDGAR
2024-06-264Islam Khalid — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR
2024-06-264Nicaise Claude — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR
2024-06-264Melincoff Gwen A — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR
2024-06-264Riley Jeffrey Scott — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR
2024-06-264RICHMAN ERIC I — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR
2024-06-264HASLER HANS PETER — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR
2024-06-264GOLDSTEIN DOV A MD — DirectorGrant/award (A): 15,000 (derivative) @ $0EDGAR
2024-04-084Mack Gene — Chief Financial OfficerGrant/award (A): 200,000 (derivative) @ $0EDGAR
2024-04-014Riley Jeffrey Scott — DirectorPurchase (P): 30,000 @ $3.86EDGAR
2024-03-284Alder Matthias — Chief Executive Officer, DirectorOption exercise (M): 18,750 · Option exercise (M): 825 · Option exercise (M): 637 · Tax withholding (F): 6,085 @ $4.06 · Option exercise (M): 18,750 (derivative) @ $0 · Option exercise (M): 825 (derivative) @ $0 · +1 moreEDGAR
2024-03-254Fuggetta Gianluca — See RemarkGrant/award (A): 50,000 (derivative) @ $0EDGAR
2024-03-254Alder Matthias — Chief Executive Officer, DirectorGrant/award (A): 370,000 (derivative) @ $0EDGAR
2023-12-224Alder Matthias — Chief Executive Officer, DirectorOption exercise (M): 637 · Sale (S): 206 @ $2.46 · Option exercise (M): 637 (derivative) @ $0EDGAR
2023-12-144Alder Matthias — Chief Executive Officer, DirectorSale (S): 1,820 @ $2.50EDGAR
2023-10-034Alder Matthias — Chief Executive Officer, DirectorOption exercise (M): 825 · Option exercise (M): 825 (derivative) @ $0EDGAR
2023-09-224Alder Matthias — Chief Executive Officer, DirectorOption exercise (M): 2,550 · Option exercise (M): 2,550 (derivative) @ $0EDGAR
2023-09-224RICHMAN ERIC I — DirectorOption exercise (M): 54,900 · Option exercise (M): 54,900 (derivative) @ $0EDGAR
2023-07-054Alder Matthias — Chief Executive Officer, DirectorOption exercise (M): 3,300 · Option exercise (M): 3,300 (derivative) @ $0EDGAR
2023-06-264Islam Khalid — DirectorGrant/award (A): 10,500 (derivative) @ $0EDGAR
2023-06-264Nicaise Claude — DirectorGrant/award (A): 10,500 (derivative) @ $0EDGAR
2023-06-264Melincoff Gwen A — DirectorGrant/award (A): 10,500 (derivative) @ $0EDGAR
2023-06-264Riley Jeffrey Scott — DirectorGrant/award (A): 10,500 (derivative) @ $0EDGAR
2023-06-264HASLER HANS PETER — DirectorGrant/award (A): 10,500 (derivative) @ $0EDGAR
2023-06-264GOLDSTEIN DOV A MD — DirectorGrant/award (A): 10,500 (derivative) @ $0EDGAR
2023-04-124Ballantyne Charles Evan — Chief Financial OfficerGrant/award (A): 100,000 (derivative) @ $0 · Grant/award (A): 50,000 (derivative) @ $0EDGAR
2023-03-274Fuggetta Gianluca — Principal Accounting OfficerGrant/award (A): 15,000 (derivative) @ $0EDGAR
2023-03-274Alder Matthias — Chief Executive Officer, DirectorGrant/award (A): 150,000 (derivative) @ $0 · Grant/award (A): 75,000 (derivative) @ $0EDGAR

Recent 8-K events — Gain Therapeutics, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-178-K8.01 — Other EventsEDGAR
2026-11-108-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-288-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-018-K8.01 — Other EventsEDGAR
2026-09-288-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2026-08-118-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-168-K8.01 — Other EventsEDGAR
2026-06-298-K8.01 — Other EventsEDGAR
2026-06-258-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-05-268-K8.01 — Other EventsEDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=GANX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs